Document:

Exhibit
10.1

 

STOCK
PURCHASE AGREEMENT

 

This
Stock Purchase Agreement (“Agreement”), dated October 13, 2020 (“Effective Date”), is by and between LOGIQ,
Inc. (the “Company”) and __________. (“Investor”).

 

		1.	The
                                         Company and Investor are executing and delivering this Agreement in reliance upon: (i)
                                         a Registration Statement and Base Prospectus filed with the United States Securities
                                         and Exchange Commission (“Commission”) on August 17, 2020 on Form S-3; and
                                         (ii) a Prospectus Supplement filed with the Commission on October 13, 2020 pursuant to
                                         Rule 424(b)(5), with both documents bearing Registration Number 333-248069;
	 	 	 

		2.	The
                                         parties desire that, upon the terms contained in this Agreement, the Company shall issue
                                         and sell to Investor and Investor shall purchase for $750,000 ("Purchase Price")
                                         150,000 registered shares of common stock of the Company (“Shares”).
	 	 	 

		3.	Closing
                                         Date. The “Closing Date” shall be the date that the Purchase Price is transmitted
                                         by wire transfer or otherwise credited to or for the benefit of the Company. The consummation
                                         of the transaction set forth in this Agreement (“Closing”) shall take place
                                         at any location agreed to between the parties and upon the satisfaction or waiver of
                                         all conditions to Closing set forth in this Agreement.
	 	 	 

		4.	Closing.
                                         On the Closing Date Investor shall purchase and the Company shall sell the Shares to
                                         Investor.
	 	 	 

		5.	Purchased
                                         Shares. On the Closing Date, or as directed by Investor, the Company shall issue and
                                         deliver the Shares to Investor.
	 	 	 

		6.	Status
                                         of the Company and Matters Related to this Agreement
	 	 	 

		a.	Due
                                         Incorporation. The Company is a corporation duly incorporated, validly existing and in
                                         good standing under the laws of the jurisdiction of its incorporation and has the requisite
                                         corporate power to own its properties and to carry on its business as presently conducted.
                                         The Company is duly qualified as a foreign corporation to do business and is in good
                                         standing in each jurisdiction where the nature of the business conducted , or property
                                         owned by it, makes such qualification necessary, other than those jurisdictions in which
                                         the failure to so qualify would not have a Material Adverse Effect. For purposes of this
                                         Agreement, a “Material Adverse Effect” shall mean a material adverse effect
                                         on the financial condition, results of operations, prospects, properties or business
                                         of the Company and its Subsidiaries taken as a whole. For purposes of this Agreement,
                                         “Subsidiary” means any corporation which more than 30% of the outstanding
                                         capital stock having (in the absence of contingencies) ordinary voting power to elect
                                         a majority of the Company’s Board of Directors (“Board”). As of the
                                         Closing Date, each Subsidiary of the Company is set forth on Schedule 6(a) to this Agreement.

 

		b.	Outstanding
                                         Stock. All issued and outstanding shares of common stock of the Company and any Subsidiary
                                         have been duly authorized and validly issued and are fully paid and non-assessable.

 

     

     

    

 

		c.	Authority;
                                         Enforceability. This Agreement has been duly authorized, executed and delivered by the
                                         Company. The Company has full corporate power and authority necessary to deliver this
                                         Agreement and to perform the obligations set forth in this Agreement.
	 	 	 

		d.	Capitalization
                                         and Additional Issuances of Common Stock. As of the date of this Agreement, the authorized
                                         and outstanding number of shares of common stock of the Company (not including the Shares)
                                         is set forth on Schedule 6(d) to this Agreement. There are no outstanding agreements
                                         or preemptive or similar rights affecting the common stock of the Company and no outstanding
                                         rights, warrants or options to acquire, or instruments convertible into or exchangeable
                                         for, or agreements or understandings with respect to the sale or issuance of any common
                                         stock of the Company or other equity interest in the Company except as described on Schedule
                                         6(d) to this Agreement. The common stock, options, warrants, agreements and other rights
                                         to acquire equity of the Company is set forth on Schedule 6(d) to this Agreement. The
                                         only officer, director, employee and consultant stock option or stock incentive plan
                                         in effect or contemplated by the Company as of the date of this Agreement is described
                                         on Schedule 6(d) to this Agreement.
	 	 	 

		e.	Consents.
                                         No consent, approval, authorization or order of any court, governmental agency, or body
                                         or arbitrator having jurisdiction over the Company or any Subsidiary, the OTC Markets
                                         Group, Inc. or the Company's shareholders is required for the sale of the Shares in accordance
                                         with this Agreement.
	 	 	 

		f.	Stop
                                         Orders. There are no stop orders in effect from the United States Securities and Exchange
                                         Commission (“Commission”) or any state securities commission or any other
                                         regulatory authority of any stop order or of any order preventing or suspending any offering
                                         of the common stock of the Company, or of the suspension of the qualification of the
                                         common stock of the Company for offering or sale in any jurisdiction or the initiation
                                         of any proceeding for any such purpose. If any such stop order is issued, the Company
                                         will promptly notify Brown Stone.
	 	 	 

		g.	Books
                                         and Records. From the date of this Agreement and until the Closing, the Company shall
                                         keep records and books of account in which full, true and correct entries will be made
                                         of all dealings or transactions in relation to its business and affairs in accordance
                                         with generally accepted accounting principles applied in the United States on a consistent
                                         basis.
	 	 	 

		h.	Governmental
                                         Authorities. From the date of this Agreement and until the Closing, the Company shall
                                         duly observe and conform in all material respects to all valid requirements of governmental
                                         authorities relating to the conduct of its business, properties and assets.

 

    2

     

    

 

		7.	Miscellaneous.

 

		a.	Notices
.. All notices, requests and demands to or upon a party to this Agreement (“Notice”), to be effective, shall be in
writing and shall be sent: (i) certified or registered mail, return receipt requested; (ii) by personal delivery against receipt;
(iii) by overnight courier; or (iv) by email and shall be deemed to have been validly served, given delivered and received: (x)
on the date indicated on the receipt, when delivered by personal delivery against receipt or by certified or registered mail;
(y) one business day after deposit with an overnight courier; or (z) in the case of email notice, when sent. Notices shall be
addressed as follows:

 

LOGIQ
INC.

85 Broad Street, 16-079

New York, NY 10004

Attn: Tom Furukawa, CEO

Email:

 

INVESTOR

_________________

_________________

_________________

Attn:

Email:

 

		b.	Counterparts
and Execution. This Agreement may be executed in any number of counterparts and by the different signatories to this Agreement
on separate counterparts, each of which, when so executed, shall be deemed an original, but all such counterparts shall constitute
one and the same instrument. This Agreement may be delivered by facsimile or email transmission.

 

    3

     

    

 

The
parties have executed this Agreement as of the Effective Date.

 

	LOGIQ INC.	 
	 	 
	By:  	                                                	 
	Printed Name:	 
	Title:	 	 
	 	 
	INVESTOR:	 
	 	 
	By: 	 	 
	Printed Name: 	 
	Title:	 	 

 

 

4Exhibit 10.1

 

Confidential

 

SUBSCRIPTION AGREEMENT

 

CC Neuberger Principal
Holdings I

200 Park Avenue, 58th Floor

New York, New York, 10166

 

Ladies and Gentlemen:

 

This Subscription Agreement
(this “Subscription Agreement”) is being entered into as of the date set forth on the signature page hereto,
by and between CC Neuberger Principal Holdings I, a Cayman Islands exempted company,
which shall be domesticated as a Delaware corporation prior to the closing of the Transaction (as defined herein) (“CCNB1”),
and the undersigned subscriber (the “Investor”), in connection with the Business Combination Agreement, dated
as of the date hereof (as may be amended, supplemented or otherwise modified from time to time, the “Merger Agreement”),
by and among CCNB1, Eagle Parent Holdings, LLC, a Delaware limited liability company (the “Company”), Sonar
Company Merger Sub, LLC, a Delaware limited liability company (“Company Merger Sub”) and the other parties thereto,
pursuant to which, among other things, Company Merger Sub will merge with and into the Company, with the Company as the surviving
company in the merger and, after giving effect to such merger, will become a subsidiary of CCNB1, on the terms and subject to the
conditions therein (the transactions contemplated by the Merger Agreement, the “Transaction”). In connection
with the Transaction, CCNB1 is seeking commitments from interested investors to purchase, following the Domestication (as defined
below) and prior to the closing of the Transaction, shares of CCNB1’s class A common
stock, par value $0.0001 per share (the “Shares”), in a private placement for a purchase price of $10.00 per
share (the “Per Share Purchase Price”). On or about the date of this Subscription Agreement, CCNB1 is entering
into subscription agreements (the “Other Subscription Agreements” and together with the Subscription Agreement,
the “Subscription Agreements”) with certain other investors (the “Other Investors” and together
with the Investor, the “Investors”), pursuant to which the Investors have agreed to purchase on the closing
date of the Transaction, inclusive of the Shares subscribed for by the Investor, an aggregate amount of up to 52,000,000 Shares,
at the Per Share Purchase Price.

 

Prior to the closing
of the Transaction (and as more fully described in the Merger Agreement), CCNB1 will
domesticate as a Delaware corporation in accordance with Section 388 of the General Corporation Law of the State of Delaware and
de-register as a Cayman Islands exempted company in accordance with Section 206 of the Cayman Islands Companies Law (2020 Revision)
(the “Domestication”).  The aggregate purchase price to be paid by
the Investor for the subscribed Shares (as set forth on the signature page hereto) is referred to herein as the “Subscription
Amount.” 

 

In connection therewith,
and in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions,
set forth herein, and intending to be legally bound hereby, each of the Investor and CCNB1 acknowledges and agrees as follows:

 

1.                  
Subscription. The Investor hereby irrevocably subscribes for and agrees to purchase from CCNB1 the number of Shares
set forth on the signature page of this Subscription Agreement on the terms and subject to the conditions provided for herein.
The Investor acknowledges and agrees that CCNB1 reserves the right to accept or reject the Investor’s subscription for the
Shares for any reason or for no reason, in whole or in part, at any time prior to its acceptance, and the same shall be deemed
to be accepted by CCNB1 only when this Subscription Agreement is signed by a duly authorized person by or on behalf of CCNB1;
CCNB1 may do so in counterpart form. Investor acknowledges and agrees that, as a result of the Domestication, the Shares that
will be purchased by the Investor and issued by CCNB1 pursuant hereto shall be shares
of common stock in a Delaware corporation (and not, for the avoidance of doubt, ordinary shares in a Cayman Islands exempted company).

 

2.                  
Closing. The closing of the sale of the Shares contemplated hereby (the “Closing”)
is contingent upon the substantially concurrent consummation of the Transaction. The Closing shall occur on the date of, and substantially
concurrently with and conditioned upon the effectiveness of, the Transaction. Upon (a) satisfaction or waiver of the conditions
set forth in Section 3 below and (b) delivery of written notice from (or on behalf of) CCNB1 to the Investor (the “Closing
Notice”), that CCNB1 reasonably expects all conditions to the closing of the Transaction to be satisfied or waived
on a date that is not less than five (5) business days from the date on which the Closing Notice is delivered to the Investor,
the Investor shall deliver to CCNB1, three (3) business days prior to the closing date specified in the Closing Notice (the “Closing
Date”), the Subscription Amount by wire transfer of United States dollars in immediately available funds to the
account(s) specified by CCNB1 in the Closing Notice. On the Closing Date, CCNB1 shall issue a number of Shares to the Investor
set forth on the signature page to this Subscription Agreement and subsequently cause such Shares to be registered in book entry
form in the name of the Investor on CCNB1’s share register; provided, however, that CCNB1’s obligation to issue the
Shares to the Investor is contingent upon CCNB1 having received the Subscription Amount in full accordance with this Section 2.
If the Closing does not occur within two (2) business days following the Closing Date
specified in the Closing Notice, CCNB1 shall promptly (but not later than one (1) business day thereafter) return the Subscription
Amount in full to the Investor. For purposes of this Subscription Agreement, “business day” shall mean a day other
than a Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or required by law to close.

 

    

     

    

 

Confidential

 

3.             Closing Conditions.

 

a.            The obligation of the parties hereto to consummate the purchase and sale of the Shares pursuant to this Subscription
Agreement is subject to the following conditions:

 

(i)               no applicable governmental authority shall have enacted, issued, promulgated, enforced or entered any judgment, order,
law, rule or regulation (whether temporary, preliminary or permanent) which is then in effect and has the effect of making consummation
of the transactions contemplated hereby illegal or otherwise restraining or prohibiting consummation of the transactions contemplated
hereby; and

 

(ii)              all conditions precedent to the closing of the Transaction under the Merger Agreement shall have been satisfied or
waived (as determined by the parties to the Merger Agreement and other than those conditions under the Merger Agreement which,
by their nature, are to be fulfilled at the closing of the Transaction, including to the extent that any such condition is dependent
upon the consummation of the purchase and sale of the Shares pursuant to this Subscription Agreement) and the closing of the Transaction
shall occur, on the Closing Date, substantially concurrently with the Closing.

 

b.           The obligation of CCNB1 to consummate the issuance and sale of the Shares pursuant to this Subscription Agreement
shall be subject to the condition that all representations and warranties of the Investor contained in this Subscription Agreement
are true and correct in all material respects (other than representations and warranties that are qualified as to materiality,
which representations and warranties shall be true in all respects) at and as of the Closing Date, and consummation of the Closing
shall constitute a reaffirmation by the Investor of each of the representations and warranties of the Investor contained in this
Subscription Agreement as of the Closing Date.

 

c.            The obligation of the Investor to consummate the purchase of the Shares pursuant to this Subscription Agreement shall
be subject to the conditions that (i) all representations and warranties of CCNB1 contained in this Subscription Agreement shall
be true and correct in all material respects (other than representations and warranties that are qualified as to materiality or
Material Adverse Effect (as defined herein), which representations and warranties shall be true in all respects) at and as of the
Closing Date, and consummation of the Closing shall constitute a reaffirmation by CCNB1 of each of the representations and warranties
of CCNB1 contained in this Subscription Agreement as of the Closing Date and (ii) all obligations, covenants and agreements of
CCNB1 required to be performed by it at or prior to the Closing Date shall have been performed in all material respects.

 

4.            Further
Assurances. The parties hereto shall execute and deliver such additional documents and take such additional actions as the
parties reasonably may deem to be practical and necessary in order to consummate the subscription as contemplated by this Subscription
Agreement and the Transaction.

 

5.            CCNB1 Representations and Warranties. CCNB1 represents and warrants to the Investor that:

 

a.            CCNB1 is an exempted company duly incorporated, validly existing and in good standing under the laws of the Cayman
Islands. CCNB1 has all power (corporate or otherwise) and authority to own, lease and operate its properties and conduct its business
as presently conducted and to enter into, deliver and perform its obligations under this Subscription Agreement. As of the Closing
Date, following the Domestication, CCNB1 will be duly incorporated, validly existing as a corporation and in good standing under
the laws of the State of Delaware.

 

    2

     

    

 

Confidential

 

b.           As of the Closing Date, the Shares will be duly authorized and, when issued and delivered to the Investor against
full payment therefor in accordance with the terms of this Subscription Agreement, the Shares will be validly issued, fully paid
and non-assessable and will not have been issued in violation of or subject to any preemptive or similar rights created under CCNB1’s
certificate of incorporation (as adopted on the Closing Date) or under the General Corporation Law of the State of Delaware. Assuming
the accuracy of the Investor's representations and warranties set forth in Section 6, in connection with the offer, sale and delivery
of the Shares in the manner contemplated by this Subscription Agreement, it is not necessary to register the offer and sale of
the Shares under the Securities Act of 1933, as amended, (the “Securities Act”).
The Shares (i) were not offered by any form of general solicitation or general advertising and (ii) are not being offered in a
manner involving a public offering under, or in a distribution in violation of, the Securities Act, or any state securities laws.

 

c.           This Subscription Agreement has been duly authorized, executed and delivered by CCNB1 and, assuming that this Subscription
Agreement constitutes the valid and binding agreement of the Investor, this Subscription Agreement constitutes the valid and binding
agreement of the Company and is enforceable against CCNB1 in accordance with its terms, except as may be limited or otherwise affected
by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights
of creditors generally, or (ii) principles of equity, whether considered at law or equity.

 

d.           The issuance and sale of the Shares and the compliance by CCNB1 with all of the provisions of this Subscription Agreement
and the consummation of the transactions contemplated herein will not conflict with or result in a breach or violation of any of
the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance
upon any of the property or assets of CCNB1 or any of its subsidiaries pursuant to the terms of (i) any indenture, mortgage, deed
of trust, loan agreement, lease, license or other agreement or instrument to which CCNB1 or any of its subsidiaries is a party
or by which CCNB1 or any of its subsidiaries is bound or to which any of the property or assets of CCNB1 is subject that would
reasonably be expected to have a material adverse effect on the business, financial condition or results of operations of CCNB1
and its subsidiaries, taken as a whole (a “Material Adverse Effect”)
or materially affect the validity of the Shares or the legal authority of CCNB1 to timely comply in all material respects with
the terms of this Subscription Agreement; (ii) result in any violation of the provisions of the organizational documents of CCNB1;
or (iii) result in any violation of any statute or any judgment, order, rule or regulation of any court or governmental agency
or body, domestic or foreign, having jurisdiction over CCNB1 or any of their properties that would reasonably be expected to have
a Material Adverse Effect or materially affect the validity of the Shares or the legal authority of CCNB1 to timely comply in all
material respects with this Subscription Agreement.

 

e.           As of their respective dates, all reports (the “SEC Reports”) required to be filed by CCNB1 with
the U.S. Securities and Exchange Commission (the “SEC”) complied in all material respects with the applicable
requirements of the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
and the rules and regulations of the SEC promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue
statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements of CCNB1
included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations
of the SEC with respect thereto as in effect at the time of filing and fairly present in all material respects the financial position
of CCNB1 as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the
case of unaudited financial statements, to normal, year-end audit adjustments. A copy of each SEC Report is available to the Investor
via the SEC’s EDGAR system. To the knowledge of CCNB1, there are no material outstanding or unresolved comments in comment
letters from the staff of the Division of Corporation Finance of the SEC with respect to any of the SEC Reports as of the date
hereof.

 

f.            Other than the Other Subscription Agreements, the Merger Agreement and any other agreement expressly contemplated
by the Merger Agreement or described in the SEC Reports, CCNB1 has not entered into any side letter or similar agreement with any
investor in connection with such investor’s direct or indirect investment in CCNB1 or with any other investor. No Other Subscription
Agreement includes terms and conditions that are materially more advantageous to any such Other Investor than Investor hereunder,
and such Other Subscription Agreements have not been amended in any material respect following the date of this Subscription Agreement.

 

    3

     

    

 

Confidential

 

g.           Except for such matters as have not had and would not be reasonably likely to have, individually or in the aggregate,
a Material Adverse Effect, as of the date hereof, there is no (i) action, suit, claim or other proceeding, in each case by or before
any governmental authority pending, or, to the knowledge of CCNB1, threatened against CCNB1 or (ii) judgment, decree, injunction,
ruling or order of any governmental entity or arbitrator outstanding against CCNB1.

 

h.           As of the date of this Subscription Agreement, the authorized capital stock of CCNB1 consists of (i) 500,000,000
Class A ordinary shares, (ii) 50,000,000 Class B ordinary shares and (iii) 1,000,000 preference shares, each with a par
value of $0.0001 per share. As of the date of this Subscription Agreement, (A) 41,400,000 Class A ordinary shares of CCNB1
are issued and outstanding, (B) 15,350,000 Class B ordinary shares of CCNB1 are issued and outstanding, (C) 24,080,000 warrants
to purchase Class A ordinary shares of CCNB1 are issued and outstanding, and (D) no preference shares are issued and
outstanding. All (1) issued and outstanding Class A ordinary shares and Class B ordinary shares of CCNB1 have been
duly authorized and validly issued, are fully paid and are non-assessable and (2) outstanding warrants have been
duly authorized and validly issued. Except as set forth above and pursuant to the Other Subscription Agreements, the Merger Agreement
and the other agreements and arrangements referred to therein or in the SEC Reports, as of the date hereof, there are no outstanding
options, warrants or other rights to subscribe for, purchase or acquire from CCNB1 any Class A ordinary shares, Class B
ordinary shares or other equity interests in CCNB1, or securities convertible into or exchangeable or exercisable for such equity
interests. As of the date hereof, CCNB1 has no subsidiaries, other than Merger Sub, and does not own, directly or indirectly, interests
or investments (whether equity or debt) in any person, whether incorporated or unincorporated. There are no shareholder agreements,
voting trusts or other agreements or understandings to which CCNB1 is a party or by which it is bound relating to the voting of
any securities of CCNB1, other than (1) as set forth in the SEC Reports and (2) as contemplated by the Merger Agreement.

 

i.            As of the date hereof, the issued and outstanding Shares of CCNB1 are registered pursuant to Section 12(b) of the
Exchange Act, and are listed for trading on the New York Stock Exchange (“NYSE”) under the symbol “PCPL”
(it being understood that the trading symbol will be changed in connection with the Transaction). Except as disclosed in CCNB1’s
filings with the SEC, as of the date hereof, there is no suit, action, proceeding or investigation pending or, to the knowledge
of CCNB1, threatened against CCNB1 by NYSE or the SEC, respectively, to prohibit or terminate the listing of CCNB1’s Shares
on NYSE or to deregister the Shares under the Exchange Act. CCNB1 has taken no action that is designed to terminate the registration
of the Shares under the Exchange Act.

 

j.            CCNB1 acknowledges and agrees that, notwithstanding anything herein to the contrary, the Shares may be pledged by
Investor in connection with a bona fide margin agreement, provided such pledge shall be (i) pursuant to an available exemption
from the registration requirements of the Securities Act or (ii) pursuant to, and in accordance with, a registration statement
that is effective under the Securities Act at the time of such pledge, and Investor effecting a pledge of Shares shall not be required
to provide CCNB1 with any notice thereof; provided, however, that neither CCNB1, the Company or their respective counsels shall
be required to take any action (or refrain from taking any action) in connection with any such pledge, other than providing any
such lender of such margin agreement with an acknowledgment that the Shares are not subject to any contractual prohibition on pledging
or lock up, the form of such acknowledgment to be subject to review and comment by CCNB1 in all respects.

 

6.            Investor
Representations and Warranties. The Investor represents and warrants to CCNB1 that:

 

a.            The Investor (i) is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act),
a “qualified purchaser” (as defined in Section 2(a)(51) of the Investment Company Act) or an institutional “accredited
investor” (within the meaning of Rule 501(a) under the Securities Act), in each case, satisfying the applicable requirements
set forth on Schedule A, (ii) is acquiring the Shares only for his, her or its own account and not for the account of others,
or if the Investor is subscribing for the Shares as a fiduciary or agent for one or more investor accounts, the Investor has full
investment discretion with respect to each such account, and the full power and authority to make the acknowledgements, representations
and agreements herein on behalf of each owner of each such account, and (iii) is not acquiring the Shares with a view to, or for
offer or sale in connection with, any distribution thereof in violation of the Securities Act (and shall provide the requested
information set forth on Schedule A). The Investor is not an entity formed for the specific purpose of acquiring the Shares
and is an “institutional account” as defined by FINRA Rule 4512(c).

 

    4

     

    

 

Confidential

 

b.            The Investor acknowledges and agrees that the Shares are being offered in a transaction not involving any public
offering within the meaning of the Securities Act and that the Shares have not been registered under the Securities Act. The Investor
acknowledges and agrees that the Shares may not be offered, resold, transferred, pledged or otherwise disposed of by the Investor
absent an effective registration statement under the Securities Act except (i) to CCNB1 or a subsidiary thereof, (ii) to non-U.S.
persons pursuant to offers and sales that occur outside the United States within the meaning of Regulation S under the Securities
Act or (iii) pursuant to another applicable exemption from the registration requirements of the Securities Act, and in each of
clauses (i) and (iii) in accordance with any applicable securities laws of the states and other jurisdictions of the United States,
and that any certificates representing the Shares shall contain a restrictive legend to such effect and, as a result, the Investor
may not be able to readily offer, resell, transfer, pledge or otherwise dispose of the Shares and may be required to bear the financial
risk of an investment in the Shares for an indefinite period of time. The Investor acknowledges and agrees that the Shares will
not immediately be eligible for resale pursuant to Rule 144 promulgated under the Securities Act. The Investor acknowledges and
agrees that it has been advised to consult legal counsel prior to making any offer, resale, transfer, pledge or disposition of
any of the Shares. The Investor acknowledges that the sale of the Shares meets the exemptions from filing under FINRA Rule 5123(b)(1)(A)
and FINRA Rule 5123(b)(1)(C) or (J), and the institutional customer exemptions from filing under FINRA Rule 2111(b).

 

c.            The Investor acknowledges and agrees that the Investor is purchasing the Shares from CCNB1. The Investor further
acknowledges that there have been no representations, warranties, covenants and agreements made to the Investor by or on behalf
of CCNB1, the Company, any of their respective affiliates or any control persons, officers, directors, employees, partners, agents
or representatives of any of the foregoing or any other person or entity, expressly or by implication, other than those representations,
warranties, covenants and agreements of CCNB1 expressly set forth in Section 5 of this Subscription Agreement.

 

d.            The Investor’s acquisition and holding of the Shares will not constitute or result in a non-exempt prohibited
transaction under Section 406 of the Employee Retirement Income Security Act of 1974, as amended, Section 4975 of the Internal
Revenue Code of 1986, as amended, or any applicable similar law.

 

e.            The Investor acknowledges and agrees that the Investor has received such information as the Investor deems necessary
in order to make an investment decision with respect to the Shares, including, with respect to CCNB1, the Transaction and the business
of the Company and its subsidiaries. Without limiting the generality of the foregoing, the Investor acknowledges that he, she or
it has reviewed CCNB1’s filings with the SEC. The Investor acknowledges and agrees that the Investor and the Investor’s
professional advisor(s), if any, have had the full opportunity to ask such questions, receive such answers and obtain such information
as the Investor and such Investor’s professional advisor(s), if any, have deemed necessary to make an investment decision
with respect to the Shares.

 

f.             The Investor became aware of this offering of the Shares solely by means of direct contact between the Investor and
CCNB1, the Company or a representative of CCNB1 or the Company, and the Shares were offered to the Investor solely by direct contact
between the Investor and CCNB1, the Company or a representative of CCNB1 or the Company. The Investor did not become aware of this
offering of the Shares, nor were the Shares offered to the Investor, by any other means. The Investor acknowledges that the Shares
(i) were not offered by any form of general advertising or, to its knowledge, general solicitation and (ii) are not being offered
in a manner involving a public offering under, or in a distribution in violation of, the Securities Act, or any state securities
laws. The Investor acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty
made by any person, firm or corporation (including, without limitation, CCNB1, the Company, the Placement Agents (defined below),
any of their respective affiliates or any control persons, officers, directors, employees, partners, agents or representatives
of any of the foregoing), other than the representations and warranties of CCNB1 contained in Section 5 of this Subscription Agreement,
in making its investment or decision to invest in CCNB1.

 

    5

     

    

 

Confidential

 

g.            The Investor acknowledges that it is aware that there are substantial risks incident to the purchase and ownership
of the Shares, including those set forth in CCNB1’s filings with the SEC. The Investor has such knowledge and experience
in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Shares, and the Investor
has sought such accounting, legal and tax advice as the Investor has considered necessary to make an informed investment decision
and the Investor has made its own assessment and has satisfied itself concerning relevant tax and other economic considerations
relative to its purchase of the Shares. The Investor will not look to the Placement Agents for all or part of any such loss or
losses the Investor may suffer and is able to sustain a complete loss on its investment in the Shares.

 

h.            Alone, or together with any professional advisor(s), the Investor has adequately analyzed and fully considered the
risks of an investment in the Shares and determined that the Shares are a suitable investment for the Investor and that the Investor
is able at this time and in the foreseeable future to bear the economic risk of a total loss of the Investor’s investment
in CCNB1. The Investor acknowledges specifically that a possibility of total loss exists.

 

i.             In making its decision to purchase the Shares, the Investor has relied solely upon independent investigation made
by the Investor. Without limiting the generality of the foregoing, the Investor has not relied on any statements or other information
provided by or on behalf of either Placement Agent or any of their respective affiliates or any control persons, officers, directors,
employees, partners, agents or representatives of any of the foregoing concerning CCNB1, the Company, the Transaction, the Merger
Agreement, this Subscription Agreement or the transactions contemplated hereby or thereby, the Shares or the offer and sale of
the Shares.

 

j.             The Investor acknowledges that the Placement Agents: (i) have not provided the Investor with any information or advice
with respect to the Shares, (ii) have not made or make any representation, express or implied as to CCNB1, the Company, the Company’s
credit quality, the Shares or the Investor’s purchase of the Shares, (iii) have not acted as the Investor’s financial
advisor or fiduciary in connection with the issue and purchase of Shares, (iv) may have acquired, or during the term of the Shares
may acquire, non-public information with respect to the Company, which, subject to the requirements of applicable law, the Investor
agrees need not be provided to it, (v) may have existing or future business relationships with CCNB1 and the Company (including,
but not limited to, lending, depository, risk management, advisory and banking relationships) and will pursue actions and take
steps that it deems or they deem necessary or appropriate to protect its or their interests arising therefrom without regard to
the consequences for a holder of Shares, and that certain of these actions may have material and adverse consequences for a holder
of Shares.

 

k.            The Investor acknowledges that it has not relied on the Placement Agents in connection with its determination as
to the legality of its acquisition of the Shares or as to the other matters referred to herein and the Investor has not relied
on any investigation that the Placement Agents, any of their affiliates or any person acting on their behalf have conducted with
respect to the Shares, CCNB1 or the Company. The Investor further acknowledges that it has not relied on any information contained
in any research reports prepared by the Placement Agents or any of their affiliates.

 

l.             The Investor acknowledges and agrees that no federal or state agency has passed upon or endorsed the merits of the
offering of the Shares or made any findings or determination as to the fairness of this investment.

 

m.           The Investor, if not an individual, has been duly formed or incorporated and is validly existing and is in good standing
under the laws of its jurisdiction of formation or incorporation, with power and authority to enter into, deliver and perform its
obligations under this Subscription Agreement.

 

n.           The execution, delivery and performance by the Investor of this Subscription Agreement are within the powers of the
Investor, have been duly authorized and will not constitute or result in a breach or default under or conflict with any order,
ruling or regulation of any court or other tribunal or of any governmental commission or agency, or any agreement or other undertaking,
to which the Investor is a party or by which the Investor is bound, and, if the Investor is not an individual, will not violate
any provisions of the Investor’s organizational documents, including, without limitation, its incorporation or formation
papers, bylaws, indenture of trust or partnership or operating agreement, as may be applicable. The signature on this Subscription
Agreement is genuine, and the signatory, if the Investor is an individual, has legal competence and capacity to execute the same
or, if the Investor is not an individual, the signatory has been duly authorized to execute the same, and, assuming that this Subscription
Agreement constitutes the valid and binding obligation of CCNB1, this Subscription Agreement constitutes a legal, valid and binding
obligation of the Investor, enforceable against the Investor in accordance with its terms except as may be limited or otherwise
affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting
the rights of creditors generally, and (ii) principles of equity, whether considered at law or equity.

 

    6

     

    

 

Confidential

 

o.            The Investor is not (i) a person or entity named on the List of Specially Designated Nationals and Blocked Persons
administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”)
or in any Executive Order issued by the President of the United States and administered by OFAC (“OFAC
List”), or a person or entity prohibited by any OFAC sanctions program, (ii) a Designated National as defined
in the Cuban Assets Control Regulations, 31 C.F.R. Part 515, or (iii) a non-U.S. shell bank or providing banking services indirectly
to a non-U.S. shell bank (each, a “Prohibited Investor”). The Investor
agrees to provide law enforcement agencies, if requested thereby, such records as required by applicable law, provided that the
Investor is permitted to do so under applicable law. If the Investor is a financial institution subject to the Bank Secrecy Act
(31 U.S.C. Section 5311 et seq.) (the “BSA”), as amended by the USA
PATRIOT Act of 2001 (the “PATRIOT Act”), and its implementing regulations
(collectively, the “BSA/PATRIOT Act”), the Investor maintains policies
and procedures reasonably designed to comply with applicable obligations under the BSA/PATRIOT Act. To the extent required, it
maintains policies and procedures reasonably designed for the screening of its investors against the OFAC sanctions programs, including
the OFAC List. To the extent required by applicable law, the Investor maintains policies and procedures reasonably designed to
ensure that the funds held by the Investor and used to purchase the Shares were legally derived and were not obtained, directly
or indirectly, from a Prohibited Investor.

 

p.            No disclosure or offering document has been prepared by Goldman Sachs &
Co. LLC, Morgan Stanley & Co. LLC, Credit Suisse Securities (USA) LLC or any of their respective affiliates (collectively,
the “Placement Agents”) in connection with the offer and sale of the
Shares.

 

q.            Neither Placement Agent, nor any of its respective affiliates nor any control persons, officers, directors, employees,
partners, agents or representatives of any of the foregoing have made any independent investigation with respect to CCNB1, the
Company or its subsidiaries or any of their respective businesses, or the Shares or the accuracy, completeness or adequacy of any
information supplied to the Investor by CCNB1.

 

r.             In connection with the issue and purchase of the Shares, neither Placement Agent has acted as the Investor’s
financial advisor or fiduciary.

 

s.            The Investor has or has commitments to have and, when required to deliver payment
to CCNB1 pursuant to Section 2 above, will have, sufficient funds to pay the Subscription
Amount and consummate the purchase and sale of the Shares pursuant to this Subscription Agreement.

 

t.             The Investor acknowledges and agrees that it is not an underwriter within the meaning of Section 2(a)(11) of the
Securities Act.

 

    7

     

    

 

Confidential

 

7.            Registration Rights.

 

a.            In the event that the Shares are not registered in connection with the consummation of the Transaction, CCNB1 agrees
that, within thirty (30) calendar days after the Closing Date, it will file with the SEC (at the its sole cost and expense) a registration
statement registering the resale of the Shares (the “Registration Statement”),
and it shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable
after the filing thereof , but no later than the earlier of (i) sixty (60) calendar days after
the filing thereof (or ninety (90) calendar days after the filing thereof if
the SEC notifies CCNB1 that it will “review” the Registration Statement) and (ii) ten (10) Business Days after CCNB1
is notified (orally or in writing, whichever is earlier) by the SEC that the Registration Statement will not be “reviewed”
or will not be subject to further review. In connection with the foregoing, Investor shall not be required to execute any lock-up
or similar agreement or otherwise be subject to any contractual restriction on the ability to transfer the Shares. In no event
shall the Investor be identified as a statutory underwriter in the Registration Statement unless requested by the SEC. CCNB1 agrees
to cause such Registration Statement, or another shelf registration statement that includes the Shares to be sold pursuant to this
Subscription Agreement, to remain effective until the earliest of (i) the third anniversary of the Closing, (ii) the date on which
the Investor ceases to hold any Shares issued pursuant to this Subscription Agreement, or (iii) on the first date on which the
Investor is able to sell all of its Shares issued pursuant to this Subscription Agreement (or shares received in exchange therefor)
under Rule 144 promulgated under the Securities Act (“Rule 144”) within 90 days without the public information,
volume or manner of sale limitations of such rule (such date, the “End Date”). Prior to the End Date, CCNB1
will use commercially reasonable efforts to qualify the Shares for listing on the applicable stock exchange. The Investor
agrees to disclose its ownership to CCNB1 upon request to assist it in making the determination with respect to Rule 144 described
in clause (iii) above. CCNB1 may amend the Registration Statement so as to convert the Registration Statement to a Registration
Statement on Form S-3 at such time after CCNB1 becomes eligible to use such Form S-3. The Investor acknowledges and agrees that
CCNB1 may suspend the use of any such registration statement if it determines that in order for such registration statement not
to contain a material misstatement or omission, an amendment thereto would be needed to include information that would at that
time not otherwise be required in a current, quarterly, or annual report under the Exchange Act, provided, that, (I) CCNB1
shall not so delay filing or so suspend the use of the Registration Statement for a period of more than ninety (90) consecutive
days or more than a total of one hundred-twenty (120) calendar days in any three hundred sixty (360) day period and (II) CCNB1
shall use commercially reasonable efforts to make such Registration Statement available for the sale by the Investor of such securities
as soon as practicable thereafter. CCNB1’s obligations to include the Shares issued pursuant to this Subscription Agreement
(or shares issued in exchange therefor) for resale in the Registration Statement are contingent upon the Investor furnishing in
writing to CCNB1 such information regarding the Investor, the securities of CCNB1 held by the Investor and the intended method
of disposition of such Shares, which shall be limited to non-underwritten public offerings, as shall be reasonably requested by
CCNB1 to effect the registration of such Shares, and shall execute such documents in connection with such registration as CCNB1
may reasonably request that are customary of a selling stockholder in similar situations.

 

b.            CCNB1 agrees to indemnify and hold harmless, to the extent permitted by law, the Investor, its directors, and officers,
employees, and agents, and each person who controls the Investor (within the meaning of the Securities Act or the Exchange Act)
and each affiliate of the Investor (within the meaning of Rule 405 under the Securities Act) from and against any and all losses,
claims, damages, liabilities and expenses (including, without limitation, any attorneys’ fees and expenses incurred in connection
with defending or investigating any such action or claim) caused by any untrue or alleged untrue statement of material fact contained
in any Registration Statement, prospectus included in any Registration Statement or preliminary prospectus or any amendment thereof
or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make
the statements therein not misleading, except insofar as the same are caused by or contained in any information furnished in writing
to CCNB1 by or on behalf of the Investor expressly for use therein.

 

c.            The Investor agrees, severally and not jointly with any person that is a party to the Other Subscription Agreements,
to indemnify and hold harmless CCNB1, its directors and officers and agents and each person who controls CCNB1 (within the meaning
of the Securities Act) against any losses, claims, damages, liabilities and expenses (including, without limitation, reasonable
attorneys’ fees) resulting from any untrue statement of material fact contained in the Registration Statement, prospectus
or preliminary prospectus or any amendment thereof or supplement thereto or any omission of a material fact required to be stated
therein or necessary to make the statements therein not misleading, but only to the extent that such untrue statement or omission
is contained in any information or affidavit so furnished in writing by or on behalf of the Investor expressly for use therein.
In no event shall the liability of the Investor be greater in amount than the dollar amount of the net proceeds received by the
Investor upon the sale of the Shares purchased pursuant to this Subscription Agreement giving rise to such indemnification obligation.

 

d.            Any person entitled to indemnification herein shall (1) give prompt written notice to the indemnifying party
of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any
person’s right to indemnification hereunder to the extent such failure has not prejudiced the indemnifying party) and (2) permit
such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such
defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party
without its consent. An indemnifying party who elects not to assume the defense of a claim shall not be obligated to pay the fees
and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless
in the reasonable judgment of legal counsel to any indemnified party a conflict of interest exists between such indemnified party
and any other of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified
party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment
of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement does
not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from
all liability in respect to such claim or litigation.

 

    8

     

    

 

Confidential

 

e.            The indemnification provided for under this Subscription Agreement shall remain in full force and effect regardless
of any investigation made by or on behalf of the indemnified party or any officer, director, employee, agent, affiliate or controlling
person of such indemnified party and shall survive the transfer of the Shares purchased pursuant to this Subscription Agreement.

 

f.             If
the indemnification provided under this Section 7 from the indemnifying party is unavailable or insufficient to hold harmless
an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying
party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party
as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative
fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative
fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action
in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material
fact, was made by, or relates to information supplied by or on behalf of, such indemnifying party or indemnified party, and the
indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to
correct or prevent such action. The amount paid or payable by a party as a result of the losses or other liabilities referred
to above shall be deemed to include, subject to the limitations set forth above, any legal or other fees, charges or expenses
reasonably incurred by such party in connection with any investigation or proceeding. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this Section 7
from any person who was not guilty of such fraudulent misrepresentation. Any contribution pursuant to this Section 7(f) by any
seller of Shares shall be limited in amount to the amount of net proceeds received by such seller from the sale of such Shares
pursuant to the Registration Statement. Notwithstanding anything to the contrary herein, in no event will any party be liable
for consequential, special, exemplary or punitive damages in connection with this Subscription Agreement.

 

g.            With a view to making available to the Investor the benefits of Rule 144 that may, at such times as Rule 144 is available
to shareholders of the Company, permit the Investors to sell securities of the Company to the public without registration, CCNB1
agrees to:

 

(i)           make
and keep public information available, as those terms are understood and defined in Rule 144;

 

(ii)          file
with the SEC in a timely manner all reports and other documents required of CCNB1 under the Securities Act and the Exchange Act
so long as CCNB1 remains subject to such requirements and the filing of such reports and other documents is required for the applicable
provisions of Rule 144; and

 

(iii)         furnish
to the Investor so long as such Investor owns the Shares acquired hereunder, promptly upon request, (A) a written statement by
CCNB1, if true, that it has complied with the reporting requirements of Rule 144, the Securities Act and the Exchange Act, (B)
a copy of the most recent annual or quarterly report of CCNB1 and such other reports and documents so filed by CCNB1 (it being
understood that the availability of such report on the SEC’s EDGAR system shall satisfy this requirement) and (C) such other
information as may be necessary to permit the Investor to sell such securities pursuant to Rule 144 without registration.

 

    9

     

    

 

Confidential

 

8.            Termination.
This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of
the parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earlier
to occur of (a) such date and time as the Merger Agreement is terminated in accordance with its terms without being consummated,
(b) upon the mutual written agreement of each of the parties hereto and the Company to terminate this Subscription Agreement,
(c) 30 days after the Outside Date (as defined in the Merger Agreement as in effect on the date hereof), if the Closing has not
occurred by such date other than as a result of a breach of Investor’s obligations hereunder (d) if any of the conditions
to Closing set forth in Section 3 of this Subscription Agreement are (i) not satisfied or waived prior to the Closing (and if
the failure to so satisfy such condition is capable of being cured prior to the Closing, such failure shall not have been cured
by the earlier of (x) thirty calendar days following receipt of written notice from the party claiming such condition has not
been satisfied or (y) the Outside Date) or (ii) not capable of being satisfied on the Closing and, in each case of (i) and (ii),
as a result thereof, the transactions contemplated by this Subscription Agreement will not be and are not consummated at the Closing
or (e) by written notice of the Investor to CCNB1 in the event the Merger Agreement is amended, supplemented or otherwise modified
on or after the date hereof in a manner that materially adversely affects the Investor (the termination events described in clauses
(a)–(e) above, collectively, the “Termination Events”); provided that nothing herein will relieve any
party from liability for any willful breach hereof prior to the time of termination, and each party will be entitled to any remedies
at law or in equity to recover losses, liabilities or damages arising from any such willful breach. CCNB1 shall notify the Investor
in writing of the termination of the Merger Agreement promptly after the termination of such agreement. Upon the occurrence of
any Termination Event, this Subscription Agreement shall be void and of no further effect and any monies paid by the Investor
to CCNB1 in connection herewith shall promptly (and in any event within one business day) following the Termination Event be returned
to the Investor.

 

9.            Trust
Account Waiver. The Investor acknowledges that CCNB1 is a blank check company with the powers and privileges to effect a merger,
asset acquisition, reorganization or similar business combination involving CCNB1 and one or more businesses or assets. The Investor
further acknowledges that, as described in CCNB1’s prospectus relating to its initial public offering dated April 23, 2020
(the “Prospectus”) available at www.sec.gov, substantially all of
CCNB1’s assets consist of the cash proceeds of CCNB1’s initial public offering and private placement of its securities,
and substantially all of those proceeds have been deposited in a trust account (the “Trust
Account”) for the benefit of CCNB1, its public shareholders and the underwriters of CCNB1’s initial public
offering. Except with respect to interest earned on the funds held in the Trust Account that may be released to CCNB1 to pay its
tax obligations and to fund certain of its working capital requirements, the cash in the Trust Account may be disbursed only for
the purposes set forth in the Prospectus. For and in consideration of CCNB1 entering into this Subscription Agreement, the receipt
and sufficiency of which are hereby acknowledged, the Investor hereby irrevocably waives any and all right, title and interest,
or any claim of any kind it has or may have in the future, in or to any monies held in the Trust Account, and agrees not to seek
recourse against the Trust Account as a result of, or arising out of, this Subscription Agreement; provided, however,
that nothing in this Section 9 shall be deemed to limit the Investor’s right, title, interest or claim to any monies held
in the Trust Account by virtue of its record or beneficial ownership of Shares currently outstanding on the date hereof, pursuant
to a validly exercised redemption right with respect to any such Shares, except to the extent that the Investor has otherwise
agreed with CCNB1 to not exercise such redemption right.

 

10.          Miscellaneous.

 

a.            Neither this Subscription Agreement nor any rights that may accrue to the parties hereunder (other than the Shares
acquired hereunder, if any) may be transferred or assigned without the prior written consent of each of the other parties hereto;
provided that (i) this Subscription Agreement and any of the Investor’s rights and obligations hereunder may be assigned
to any fund or account managed by the same investment manager as the Investor or by an affiliate (as defined in Rule 12b-2 of the
Exchange Act) of such investment manager without the prior consent of CCNB1 and (ii) the Investor's rights under Section 7 may
be assigned to an assignee or transferee of the Shares; provided further that prior to such assignment any such assignee shall
agree in writing to be bound by the terms hereof; provided, that no assignment pursuant to clause (i) of this Section 10 shall
relieve the Investor of its obligations hereunder.

 

b.            CCNB1 may request from the Investor such additional information as CCNB1 may deem necessary to register the resale
of the Shares and evaluate the eligibility of the Investor to acquire the Shares, and the Investor shall promptly provide such
information as may reasonably be requested to the extent readily available; provided, that, CCNB1 agrees to keep any such information
provided by Investor confidential other than as necessary to include in any registration statement CCNB1 is required to file hereunder.
The Investor acknowledges and agrees that if it does not provide CCNB1 with such requested information, CCNB1 may not be able to
register the Investor's Shares for resale pursuant to Section 7 hereof. The Investor acknowledges that CCNB1 may file a copy of
this Subscription Agreement with the SEC as an exhibit to a periodic report or a registration statement of CCNB1.

 

    10

     

    

 

Confidential

 

c.            The Investor acknowledges that CCNB1, the Company, the Placement Agents and others will rely on the acknowledgments,
understandings, agreements, representations and warranties contained in this Subscription Agreement, including Schedule A hereto.
Prior to the Closing, the Investor agrees to promptly notify CCNB1, the Company and the Placement Agents if any of the acknowledgments,
understandings, agreements, representations and warranties set forth in Section 6 above are no longer accurate in any material
respect (other than those acknowledgments, understandings, agreements, representations and warranties qualified by materiality,
in which case the Investor shall notify CCNB1 and the Placement Agent if they are no longer accurate in any respect). The Investor
acknowledges and agrees that each purchase by the Investor of Shares from CCNB1 will constitute a reaffirmation of the acknowledgments,
understandings, agreements, representations and warranties herein (as modified by any such notice) by the Investor as of the time
of such purchase.

 

d.            CCNB1, the Company and the Placement Agents are each entitled to rely upon this Subscription Agreement and each is
irrevocably authorized to produce this Subscription Agreement or a copy hereof to any interested party in any administrative or
legal proceeding or official inquiry with respect to the matters covered hereby; provided, however, that the foregoing
clause of this Section 10(d) shall not give the Company or the Placement Agents any rights other than those expressly set forth
herein and, without limiting the generality of the foregoing and for the avoidance of doubt, in no event shall the Company be entitled
to rely on any of the representations and warranties of CCNB1 set forth in this Subscription Agreement.

 

e.            All of the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall
survive the Closing.

 

f.             This Subscription Agreement may not be modified, waived or terminated (other than pursuant to the terms of Section
8 above) except by an instrument in writing, signed by each of the parties hereto, provided, however, that no modification
or waiver by CCNB1 of the provisions of this Subscription Agreement shall be effective without the prior written consent of the
Company (other than modifications or waivers that are solely ministerial in nature or otherwise immaterial and do not affect any
economic or any other material term of this Subscription Agreement). No failure or delay of either party in exercising any right
or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or
any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other or further
exercise thereof or the exercise of any other right or power. The rights and remedies of the parties hereunder are cumulative and
are not exclusive of any rights or remedies that they would otherwise have hereunder.

 

g.            This Subscription Agreement (including the schedule hereto) constitutes the entire agreement, and supersedes all
other prior agreements, understandings, representations and warranties, both written and oral, among the parties, with respect
to the subject matter hereof. Except as set forth in Section 8, Section 10(c), Section 10(d), Section 10(f), this Section 10(g),
the last sentence of Section 10(k) and Section 11 with respect to the persons specifically referenced therein, and Section 6 with
respect to the Placement Agents, this Subscription Agreement shall not confer any rights or remedies upon any person other than
the parties hereto, and their respective successors and assigns, and the parties hereto acknowledge that such persons so referenced
are third party beneficiaries of this Subscription Agreement for the purposes of, and to the extent of, the rights granted to them,
if any, pursuant to the applicable provisions; provided, that, notwithstanding anything to the contrary contained in this Subscription
Agreement, the Company is an intended third party beneficiary of each of the provisions of this Subscription Agreement.

 

h.            Except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit
of the parties hereto and their heirs, executors, administrators, successors, legal representatives, and permitted assigns, and
the agreements, representations, warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and
be binding upon, such heirs, executors, administrators, successors, legal representatives and permitted assigns.

 

i.             If any provision of this Subscription Agreement shall be adjudicated by a court of competent jurisdiction to be invalid,
illegal or unenforceable, the validity, legality or enforceability of the remaining provisions of this Subscription Agreement shall
not in any way be affected or impaired thereby and shall continue in full force and effect.

 

    11

     

    

 

Confidential

 

j.             This Subscription Agreement may be executed in one or more counterparts (including by facsimile or electronic mail
or in .pdf) and by different parties in separate counterparts, with the same effect as if all parties hereto had signed the same
document. All counterparts so executed and delivered shall be construed together and shall constitute one and the same agreement.

 

k.            The parties hereto acknowledge and agree that irreparable damage would occur in the event that any of the provisions
of this Subscription Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly
agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Subscription Agreement, without
posting a bond or undertaking and without proof of damages, to enforce specifically the terms and provisions of this Subscription
Agreement, this being in addition to any other remedy to which such party is entitled at law, in equity, in contract, in tort or
otherwise. The parties hereto acknowledge and agree that the Company shall be entitled to specifically enforce the Investor’s
obligations to fund the Subscription Amount and the provisions of the Subscription Agreement, in each case, on the terms and subject
to the conditions set forth herein.

 

l.             This Subscription Agreement shall be governed by and construed in accordance with the laws of the State of Delaware
(regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof) as to all matters
(including any action, suit, litigation, arbitration, mediation, claim, charge, complaint, inquiry, proceeding, hearing, audit,
investigation or reviews by or before any governmental entity related hereto), including matters of validity, construction, effect,
performance and remedies.

 

m.           Each party hereto hereby, and any person asserting rights as a third party beneficiary may do so only if he, she
or it, irrevocably agrees that any action, suit or proceeding between or among the parties hereto, whether arising in contract,
tort or otherwise, arising in connection with any disagreement, dispute, controversy or claim arising out of or relating to this
Subscription Agreement or any related document or any of the transactions contemplated hereby or thereby (“Legal Dispute”)
shall be brought only to the exclusive jurisdiction of the courts of the State of Delaware or the federal courts located in the
State of Delaware, and each party hereto hereby consents to the jurisdiction of such courts (and of the appropriate appellate courts
therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection
that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any
such suit, action or proceeding that is brought in any such court has been brought in an inconvenient forum. During the period
a Legal Dispute that is filed in accordance with this Section 10(m) is pending before a court, all actions, suits or proceedings
with respect to such Legal Dispute or any other Legal Dispute, including any counterclaim, cross-claim or interpleader, shall be
subject to the exclusive jurisdiction of such court. Each party hereto and any person asserting rights as a third party beneficiary
may do so only if he, she or it hereby waives, and shall not assert as a defense in any Legal Dispute, that (a) such party
is not personally subject to the jurisdiction of the above named courts for any reason, (b) such action, suit or proceeding
may not be brought or is not maintainable in such court, (c) such party’s property is exempt or immune from execution,
(d) such action, suit or proceeding is brought in an inconvenient forum, or (e) the venue of such action, suit or proceeding
is improper. A final judgment in any action, suit or proceeding described in this Section 10(m) following the expiration of any
period permitted for appeal and subject to any stay during appeal shall be conclusive and may be enforced in other jurisdictions
by suit on the judgment or in any other manner provided by applicable Laws. EACH OF THE PARTIES HERETO AND ANY PERSON ASSERTING
RIGHTS AS A THIRD PARTY BENEFICIARY MAY DO SO ONLY IF HE, SHE OR IT IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT TO TRIAL BY
JURY ON ANY CLAIMS OR COUNTERCLAIMS ASSERTED IN ANY LEGAL DISPUTE RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
HEREBY AND FOR ANY COUNTERCLAIM RELATING THERETO. IF THE SUBJECT MATTER OF ANY SUCH LEGAL DISPUTE IS ONE IN WHICH THE WAIVER OF
JURY TRIAL IS PROHIBITED, NO PARTY HERETO NOR ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY SHALL ASSERT IN SUCH LEGAL
DISPUTE A NONCOMPULSORY COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
HEREBY. FURTHERMORE, NO PARTY HERETO NOR ANY PERSON ASSERTING RIGHTS AS A THIRD PARTY BENEFICIARY SHALL SEEK TO CONSOLIDATE ANY
SUCH LEGAL DISPUTE WITH A SEPARATE ACTION OR OTHER LEGAL PROCEEDING IN WHICH A JURY TRIAL CANNOT BE WAIVED.

 

    12

     

    

 

Confidential

 

11.           Non-Reliance and Exculpation. The Investor acknowledges that it is not relying upon, and has not relied upon, any
statement, representation or warranty made by any person, firm or corporation (including, without limitation, the
Placement Agents, any of their respective affiliates or any control persons, officers, directors, employees, partners, agents
or representatives of any of the foregoing), other than the statements, representations and warranties of CCNB1 expressly contained
in Section 5 of this Subscription Agreement, in making its investment or decision to invest in CCNB1. The Investor acknowledges
and agrees that none of (i) any other investor pursuant to this Subscription Agreement or any other subscription agreement related
to the private placement of the Shares (including the investor’s respective affiliates or any control persons, officers,
directors, employees, partners, agents or representatives of any of the foregoing), (ii) the
Placement Agents, their respective affiliates or any control persons, officers, directors, employees, partners, agents or representatives
of any of the foregoing, or (iii) any other party to the Merger Agreement or any Non-Party Affiliate (other than CCNB1 with
respect to the previous sentence), shall have any liability to the Investor, or to any other investor, pursuant to, arising out
of or relating to this Subscription Agreement or any other subscription agreement related to the private placement of the Shares,
the negotiation hereof or thereof or its subject matter, or the transactions contemplated hereby or thereby, including, without
limitation, with respect to any action heretofore or hereafter taken or omitted to be taken by any of them in connection with the
purchase of the Shares or with respect to any claim (whether in tort, contract or otherwise) for breach of this Subscription Agreement
or in respect of any written or oral representations made or alleged to be made in connection herewith, as expressly provided herein,
or for any actual or alleged inaccuracies, misstatements or omissions with respect to any information or materials of any kind
furnished by CCNB1, the Company, the Placement Agents or any Non-Party Affiliate concerning CCNB1, the Company, the Placement Agents,
any of their controlled affiliates, this Subscription Agreement or the transactions contemplated hereby. For purposes of this Subscription
Agreement, “Non-Party Affiliates” means each former, current or future officer, director, employee, partner, member,
manager, direct or indirect equityholder or affiliate of CCNB1, the Company, any Placement Agent or any of CCNB1’s, the Company’s
or any Placement Agent’s controlled affiliates or any family member of the foregoing.

 

12.           Disclosure. CCNB1 shall, by 9:00 a.m., New York City time, on the first (1st) Business Day immediately following
the date of this Subscription Agreement, issue one or more press releases or file with the SEC a Current Report on Form 8-K (collectively,
the “Disclosure Document”) disclosing all material terms of the transactions contemplated hereby and by the
Other Subscription Agreements, the Transaction and any other material, nonpublic information that CCNB1 has provided to the Investor
at any time prior to the filing of the Disclosure Document. Upon the issuance of the Disclosure Document, to the actual knowledge
of CCNB1, the Investor shall not be in possession of any material, non-public information received from CCNB1 or any of its officers,
directors, or employees or agents, and the Investor shall no longer be subject to any confidentiality or similar obligations under
any current agreement, whether written or oral, with CCNB1 or any of its affiliates, relating to the transactions contemplated
by this Subscription Agreement. Notwithstanding anything in this Subscription Agreement to the contrary, CCNB1 shall not publicly
disclose the name of the Investor or any of its affiliates or advisers, or include the name of the Investor or any of its affiliates
or advisers in any press release or in any filing with the SEC or any regulatory agency or trading market, without the prior written
consent of the Investor, except (i) as required by the federal securities law or pursuant to other routine proceedings of
regulatory authorities, (ii) to the extent such disclosure is required by law, at the request of the staff of the SEC or regulatory
agency or under the regulations of any national securities exchange on which CCNB1’s securities are listed for trading or
(iii) to the extent such announcements or other communications contain only information previously disclosed in a public statement,
press release or other communication previously approved in accordance with this Section 12.

 

[SIGNATURE
PAGES FOLLOW]

 

    13

     

    

 

Confidential

 

IN WITNESS WHEREOF,
the Investor has executed or caused this Subscription Agreement to be executed by its duly authorized representative as of the
date set forth below.

 

	Name of Investor:	 	State/Country of Formation or Domicile:
	 	 	 
	By:	 	 	 
	Name:	 	 	 
	Title:	 	 	 
	 	 	 
	Name in which Shares are to be registered (if different):	 	Date: ________, 2020
	 	 	 
	Investor’s EIN:	 	 
	 	 	 
	Business Address-Street:	 	Mailing Address-Street (if different):
	 	 	 
	City, State, Zip:	 	City, State, Zip:
	 	 	 
	Attn:	 	 	Attn:	 
	 	 	 
	Telephone No.:	 	Telephone No.:
	Facsimile No.:	 	Facsimile No.:
	 	 	 
	Number of Shares subscribed for:	 	 
	 	 	 
	Aggregate Subscription Amount: $	 	Price Per Share: $10.00

 

You must pay the Subscription
Amount by wire transfer of United States dollars in immediately available funds to the account specified by CCNB1 in the Closing
Notice.

 

    

     

    

 

Confidential

 

IN WITNESS WHEREOF,
CCNB1 has accepted this Subscription Agreement as of the date set forth below.

 

	 	CC NEUBERGER PRINCIPAL HOLDINGS I
	 	 	 
	 	 	 
	 	By:	 
	 	Name: 	Douglas Newton
	 	Title: 	Authorized Signatory
	 	 	 
	Date:                   , 2020

 

    

     

    

 

SCHEDULE A 

 

ELIGIBILITY
REPRESENTATIONS OF THE INVESTOR

 

	A.	QUALIFIED INSTITUTIONAL BUYER STATUS

 

	 	(Please check the applicable subparagraphs):

 

	 	☐  We are a “qualified institutional buyer”
(as defined in Rule 144A under the Securities Act (a “QIB”)).

 

	B.	INSTITUTIONAL ACCREDITED INVESTOR STATUS

 

	 	(Please check the applicable subparagraphs):

 

	 	1.	☐  We are an “accredited investor” (within the meaning of Rule 501(a) under the Securities Act or an entity in which all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act), and have marked and initialed the appropriate box on the following page indicating the provision under which we qualify as an “accredited investor.”

 

	 	2. 	☐  We are not a natural person.

 

Rule 501(a), in relevant part, states
that an “accredited investor” shall mean any person who comes within any of the below listed categories, or who the
issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person.
The Investor has indicated, by marking and initialing the appropriate box below, the provision(s) below which apply to the Investor
and under which the Investor accordingly qualifies as an “accredited investor.”

 

☐  Any
bank, registered broker or dealer, insurance company, registered investment company, business development company, or small business
investment company;

 

☐  Any
plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political
subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

☐  Any
employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company,
or registered investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;

 

☐  Any
organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, similar business trust, or partnership,
not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

☐  Any
trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated
person; or

 

☐  Any
entity in which all of the equity owners are accredited investors meeting one or more of the above tests.

 

This page
should be completed by the Investor

and constitutes
a part of the Subscription Agreement.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}]]